These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7333195)

  • 41. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevention of viral hepatitis B in exposure to carriers of HBsAG in Plzen in 1998].
    Pazdiora P; Petríková V; Fránová D
    Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):153-9. PubMed ID: 10658343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of serum DNA polymerase activities in hepatitis B carriers.
    Chin Med J (Engl); 1980 Mar; 93(3):173-6. PubMed ID: 6766848
    [No Abstract]   [Full Text] [Related]  

  • 44. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 45. [The epidemiologic and public aspects of HBsAg carriers (author's transl)A1].
    Eynat R
    Harefuah; 1977 Nov; 93(10):298-301. PubMed ID: 604207
    [No Abstract]   [Full Text] [Related]  

  • 46. [Outpatient follow-up of HBsAg-positive blood donors].
    Glasa J; Holomán J; Stancek D; Kupcová V; Jambor P; Páleníková O; Brixová E
    Bratisl Lek Listy; 1988 Mar; 89(3):220-5. PubMed ID: 3390730
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The liver of HBs Ag healthy carriers (author's transl)].
    Feroldi J; Brette R; Trepo C; Mallet-Guy Y; Rouiller D; Chevallier-Queyron P; Allard C
    Arch Anat Cytol Pathol; 1981; 29(1):5-15. PubMed ID: 7212784
    [No Abstract]   [Full Text] [Related]  

  • 49. [Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers].
    Zlotnick A; Levo Y; Fishel R; Ehrenfeld M; Levy M; Shouval D; Eliakin M
    Harefuah; 1979 Aug; 97(3-4):55-7. PubMed ID: 540822
    [No Abstract]   [Full Text] [Related]  

  • 50. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What should we clinicians do for healthy, asymptomatic, HBsAg-positive carriers?
    McMahon BJ
    Hepatology; 1993 Oct; 18(4):1014-6. PubMed ID: 8406347
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
    Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
    Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
    [No Abstract]   [Full Text] [Related]  

  • 53. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term prognosis of HBsAg positive hepatopathy.
    Seidlová V
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():287-98. PubMed ID: 2949508
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinico-laboratory and morphological characteristics of hepatitis B antigen carriers].
    Podlevskiĭ AF; Evdokimova TV
    Sov Med; 1982; (9):24-8. PubMed ID: 7147069
    [No Abstract]   [Full Text] [Related]  

  • 56. [Recent advances in hepatitis (author's transl)].
    Kaito I
    Masui; 1979 Oct; 28(10):1005-11. PubMed ID: 117154
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical studies of HB-antigen (author's transl)].
    Sasaki H; Kamimura T; Sekine T
    Rinsho Byori; 1975 Jun; 23(6):400-5. PubMed ID: 1236998
    [No Abstract]   [Full Text] [Related]  

  • 58. [Demonstration of Dane's particles and circulating immunocomplexes HBsAg in chronic forms of hepatitis type B in electron microscope (author's transl)].
    Jelínková A; Helm R; Benda R; Stránský J; Novák M
    Cesk Epidemiol Mikrobiol Imunol; 1981 Apr; 30(3):148-55. PubMed ID: 6454503
    [No Abstract]   [Full Text] [Related]  

  • 59. [Severe neonatal hepatitis B transmitted by asymptomatic carrier mother (author's transl)].
    Ruiz Extremera A; Salmerón Escobar FJ; Loscertales Abril M; López Cueto A; Hernández Gómez MV; Bernal Zamora C; Molina Font JA
    An Esp Pediatr; 1981 Sep; 15(3):284-8. PubMed ID: 7332140
    [No Abstract]   [Full Text] [Related]  

  • 60. [Selective studies of humoral immunity in carriers of HBs antigen].
    Bartelik S; Partyka M; Sopala E
    Wiad Lek; 1978 Mar; 31(6):375-8. PubMed ID: 654286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.